Aurobindo Pharma profit increases 10% at Rs 571 cr in June quarter

Revenue from operations rose to Rs 6,850.5 crore from Rs 6,236 crore in the year-ago period

q1 results, earnings, companies, india inc, corporate

Illustration: Ajay Mohanty

Press Trust of India New Delhi

Listen to This Article

Aurobindo Pharma on Saturday said its consolidated net profit increased 10 per cent to Rs 571 crore in the first quarter ended June 30, 2023, on account of robust sales across regions.
The drug firm had reported a net profit of Rs 520.5 crore in April-June 2022-23. Revenue from operations rose to Rs 6,850.5 crore from Rs 6,236 crore in the year-ago period, the Hyderabad-based firm said in a statement.
With the product pipeline continuing to advance, and execution of growth drivers proceeding as planned, the company is confident that its fundamental strengths position it to create an upward trajectory, Vice-Chairman and Managing Director K Nithyananda Reddy said.
"Looking ahead, we are confident in executing our growth initiatives and creating long-term value for our shareholders," Reddy said.

Also Read

Torrent Group capitalisation tops Rs 1 trn fuelled by acquisitions, EV push

Torrent Pharma's net profit rises 7% at Rs 378 crore in April-June quarter

Sun Pharma Q1 net profit drops 2% YoY, Revenue up 11%; US sales at $471 mn

Sun Pharma recalls over 24K pre-filled syringes of generic medication in US

Domestic drug makers Sun Pharma, Alembic recall drugs in US market

Cube Highways Trust reports Rs 781 cr consolidated net income in June qtr

Crompton Greaves net profit falls 3.1% to Rs 122.03 cr in June quarter

IREDA reports Q1 net profit of Rs 295 cr, loan book grows to Rs 47,207 cr

Kirloskar Industries profit after tax dips 9% to Rs 94 cr in June quarter

JK Cement profit declines 29.4% to Rs 113.46 crore in June quarter

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Aug 12 2023 | 9:22 PM IST

Explore News